PUDFA: DepoMed, Inc. — Serada, May 31, 2013

Read more »

Earnings: Athersys Inc. — May 16, 2013

Read more »

Your Biotech Calendar, August 28: PDUFA Dates, SEC Filings, Financings

At OneMedPlace, our goal is to be your eyes and ears to the biotech and life sciences sector: putting into perspective what we’ve seen so far, and providing you with snapshots of and what’s upcoming.

Read more »

2012 BDO IPO Halftime Report: Current Market Trends

As Ryan Starkes, Partner and a Practice Leader within BDO’s Technology and Life Sciences Industry Group informs us, BDO is interested in emerging growth life science companies particularly those planning on exploring international development. All companies looking to utilize the capital markets in the U.S., including those in the life sciences industry, have always had to navigate particularly perplexing regulatory requirements.

Read more »

The Briefing Room, August 24: The Week That Was in Microcap Biotech Stocks

OneMedPlace introduces a new series, “The Briefing Room”, capturing the past week’s most important developments in microcap life sciences indexes. This week, we feature Star Scientific, Kips Bay Medical, XOMA and Stellar Pharmaceuticals.

Read more »

Release: Epion Health and CaerVision Partner in a $3.5 Million Tablet Initiative

Epion Health announces a partnership with CaerVision to deploy tablets at the point of care. CaerVision has allocated $3.5 million dollars to this initiative.

Read more »

June 2012

In our June Research Report, OneMedResearch explores the potential impact of the JOBS Act on the life sciences sector. This […]

Read more »

Ellenoff is Enthusiastic About the Power of Crowdfunding

Doug Ellenoff, a founding partner at Ellenoff Grossman & Schole, a New York-based law firm that focuses on securities law, has been very involved in understanding crowdfunding and the implications of the Job’s Act.

Read more »

MRI Intervention’s Clearpoint Technology: The Future of MRI-Guided Surgery?

Siemens, BrainLab, and Boston Scientific have partnered with a company with the first FDA-approved technology that allows surgeons to see, in real-time, into a patient’s brain during any of the 2.2 million minimally-invasive neuro procedures that happen every year in the U.S.

Read more »

OneMedRadio: How Pluristem’s PLX Cells Saved a Dying Child

Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) recently announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition.

Read more »